U.S. House Committee Launches Probe of Allergan Patent Deal
A U.S. House of Representatives committee launched a probe into drugmaker Allergan's deal to transfer some of its patents to a Native American tribe to shield them from review, according to a report in Bloomberg.
A bipartisan group of four representatives from the House Oversight and Government Committee, including Republican Chairman Trey Gowdy and top Democrat Elijah Cummings, sent a letter to the company on Tuesday saying the arrangement could “impair competition across the pharmaceutical industry.”
Allergan said last month that it was transferring patents on its dry eye medication Restasis to New York’s Saint Regis Mohawk Tribe, which agreed to exclusively license them back to the company in exchange for ongoing payments.
The representatives asked Allergan to provide documents about its agreements with the tribe, financial details about the drug covered by the patents and documents on whether the drugmaker is considering similar arrangements for its other drugs.
You must be logged in to leave a comment.